Circulating multiple metals and mortality after myocardial infarction: incremental value beyond GRACE

Minmin Wu1,2,3, Junhan Chen1,2, Zhijie Lin1,2

  • 1Department of Cardiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital.

Insights

Elevated plasma copper, lead, and strontium levels are linked to increased mortality risk in myocardial infarction (MI) survivors. Incorporating an environmental metal risk score (ERS) improved prognostic accuracy in clinical risk models.

Area of Science:

  • Cardiovascular Medicine
  • Environmental Health
  • Toxicology

Background:

  • Emerging evidence links heavy metals (e.g., arsenic, cadmium, lead) to cardiovascular disease.
  • Current clinical risk stratification for myocardial infarction (MI) patients does not account for metal exposure.
  • This gap highlights the need to investigate the prognostic impact of metals in post-MI populations.

Purpose of the Study:

  • To investigate the association between plasma metal concentrations and all-cause mortality in patients post-MI.
  • To develop and validate an environmental metal risk score (ERS) for improved risk prediction.
  • To assess the incremental prognostic value of ERS when added to the established GRACE risk score.

Main Methods:

  • Prospective cohort study of 1,283 post-MI patients undergoing percutaneous coronary intervention (PCI).
  • Plasma levels of 19 metals measured using inductively coupled plasma mass spectrometry.
  • Multivariable Cox models and elastic net regularized Cox models used to assess associations and derive ERS.

Main Results:

  • 122 all-cause mortality events occurred during a median follow-up of 4.28 years.
  • Higher plasma copper, lead, and strontium levels were significantly associated with increased all-cause mortality.
  • The environmental metal risk score (ERS) improved risk discrimination and reclassification when added to the GRACE score.

Conclusions:

  • Plasma copper, lead, and strontium are associated with mortality risk in post-MI patients.
  • The developed ERS demonstrates potential for enhancing cardiovascular risk prediction.
  • Further validation in independent cohorts is recommended prior to clinical application.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...